glp-1 reactive hypoglycemia Thoughts on glp1 's for hypoglycemia? Frontiers | Mechanisms of action
Description
doi: 10.2337/db16-1344
Uneven texture and tone
The CBO analysis found that the annual cost to cover these medications would be $5,600 per person on the drug in 2026, decreasing to $4,300 in 2034
pricing not disclosed pre-assessment
A study in a well-known medical journal found semaglutide helps with weight loss and heart health in post-surgical patients
Both Ruhoy and Kaufman appear to have glommed onto these drugs via the 700-plus doctors MASTERMINDS network of health providers in communication with each other about ME/CFS, FM, MCAS, POTS, long COVID, etc
